Element Biosciences Stock
HealthTechLooking to sell Element Biosciences Stock or Options? Get a free valuation
Founded: 2017Funding to Date: $408M
Visit websiteElement Biosciences develops tools for genetic analysis, designed to cater to the research and diagnostic markets. The company's technology involves a high-performance, modular DNA sequencing platform that provides high-quality data and flexible workflows. This makes next-generation sequencing technology more accessible, empowering medical researchers to enhance and advance their research.
Investors Include:
Meritech Capital Partners, Fusion Fund, Alexandria Venture Investments, Logos Capital, Foresite Capital, Janus Henderson Investors, JS Capital Management, Venrock, RA Capital Management, T. Rowe Price, Morgan Stanley, Fidelity Management & Research.